Hemolytic uremic syndrome in adults;Syndromes hémolytiques et urémiques de l'adulte

Nephrologie et Therapeutique

Volumn 6, Issue 4, 2010, Pages 258-271

  Hertig, Alexandre ^a   Ridel, Christophe ^a   Rondeau, Éric ^a  

^a HÔPITAL TENON   (France)

Author keywords

Factor H; Hemolytic uremic syndrome; Plasma exchanges; Renal failure; Shigatoxin

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; AUTOANTIBODY; BACTERIAL TOXIN; BEVACIZUMAB; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; CYCLOSPORIN A; GEMCITABINE; IMMUNOSUPPRESSIVE AGENT; MITOMYCIN C; MONOCLONAL ANTI C5 ANTIBODY; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN; RITUXIMAB; STEROID; TACROLIMUS; THROMBOMODULIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ABNORMAL FECES; ACUTE KIDNEY FAILURE; ANTIPHOSPHOLIPID SYNDROME; CHRONIC KIDNEY DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; DIARRHEA; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM CELL; ENTEROBACTERIACEAE; ESCHERICHIA COLI O157; GENE MUTATION; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; HEMOLYSIS; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HETEROZYGOTE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS; MICROTHROMBUS; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMA TRANSFUSION; PLASMAPHERESIS; PROGNOSIS; PROTEIN DEFICIENCY; PUERPERIUM; RADIATION INJURY; RECURRENT DISEASE; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; SCLERODERMA; STEROID THERAPY; SURVIVAL; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULARIZATION;

EID: 77954834480     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2010.03.002     Document Type: Short Survey

References (118)

1. Niaudet P. Syndrome hémolytique et urémique de l'enfant. EMC (Elsevier Masson SAS, Paris), Pédiatrie-Maladies infectieuses, 4-084-D-15, 2004.
2. Coppo P, Vernant JP, Veyradier A, Frémeaux-Bacchi V, Mira JP, Guidet B, et al. Purpura thrombotique thrombocytopénique et autres syndromes de microangiopathie thrombotique. EMC (Elsevier Masson SAS, Paris), Hématologie, 13-020-D-10, 2005.
3. G.A. Hosler, A.M. Cusumano, and G.M. Hutchins Thrombotic thrombocytopenic purpura and haemolytic uremic syndrome are distinct pathologic entities Arch Pathol Lab Med 127 2003 834 839
4. G.G. Levy, W.C. Nichols, E.C. Lian, T. Foroud, J.N. Mcclintick, and B.M. Mcgee Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura Nature 413 2001 488 494
5. J.N. George Thrombotic thrombocytopenic purpura N Engl J Med 354 2006 1927 1935
6. H.M. Tsai The molecular biology of thrombotic microangiopathy Kidney Int 70 2006 16 23
7. P.I. Tarr, C.A. Gordon, and W.L. Chandler Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome Lancet 365 2005 1073 1078
8. P.J. Medina, J.M. Sipols, and J.N. George Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Curr Opin Hematol 8 2001 286 293
9. N. Besbas, D. Karpman, D. Landau, C. Loirat, W. Proesmans, and G. Remuzzi A classification of haemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders Kidney Int 70 2006 423 431
10. H.C. Kwaan Clinicopathologic features of thrombotic thrombocytopenic purpura Semin Hematol 24 1987 71 81
11. Galbusera M, Noris M, Rossi C, Orisio S, Caprioli J, Ruggeri Z, et al. Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombo.
12. J.N. George, R.O. Gilcher, J.W. Smith, L. Chandler, D. Duvall, and C. Ellis Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: diagnosis and management J Clin Apheresis 13 1998 120 125
13. H. Karch, M. Bitzan, R. Pietsch, K.O. Stenger, H. von Wulffen, and J. Heesemann Purified verotoxins of Escherichia coli 0157. H7 decrease prostacyclin synthesis by endothelial cells Microb Pathog 5 1988 215 221
14. F. Koster, J. Levin, L. Walker, and K.S. Tung Hemolytic uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes N Engl J Med 298 1978 927 933
15. J. Konowalchuk, J.I. Speirs, and S. Stavric Vero response to a cytotoxin of Escherichia coli Infect Immun 18 1977 775 779
16. M.A. Karmali, B.T. Steele, M. Petric, and C. Lim Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools Lancet 1 1983 619 620
17. C.A. Lingwood Verotoxin-binding in human renal sections Nephron 66 1994 21 28
18. D.G. Motto, A.K. Chauhan, G. Zhu, J. Homeister, C.B. Lamb, and K.C. Desch Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice J Clin Invest 115 2005 2752 2761
19. D.M. Te Loo, L.A. Monnens, T.J. Van der Velden, M. Vermeer, F. Preyers, and P.N. Demacker Binding and transfer of verototoxin by polynuclear leukocytes in hemolytic uremic syndrom Blood 95 2000 3396 3402
20. A. Petermann, G. Offermann, A. Distler, and A.M. Sharma Familial haemolytic-uremic syndrome in three generations Am J Kidney Dis 32 1998 1063 1067
21. S. Chinnakotla, J.P. Leone, M.E. Fidler, M.D. Hammeke, and S. Tarantolo Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient Transplantation 70 2000 550 552
22. M. Furlan, and B. Lämmle Von Willebrand factor in thrombotic thrombocytopenic purpura Thromb Haemost 82 1999 592 600
23. M. Furlan, and B. Lämmle Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura: new insights into underlying biochemical mechanism Nephrol Dial Transplant 15 2000 1112 1114
24. M. Furlan, R. Robles, M. Galbusera, G. Remuzzi, P.A. Kyrle, and B. Brenner Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome N Engl J Med 339 1998 1578 1584
25. D.Y. Leung, J.L. Moake, P.L. Havens, M. Kim, and J.S. Pober Lytic antiendothelial cell antibodies in haemolytic-uremic syndrome Lancet 2 1988 183 186
26. M. Noris, G. Remuzzi, and H.U.S. Are TTP genetically determined? Kidney Int 53 1998 1085 1086
27. V. Pichette, S. Querin, W. Schurch, G. Brun, G. Lehmer-Netsch, and J.M. Delage Familial hemolytic-uremic syndrome and homozygous factor H deficiency Am J Kidney Dis 24 1994 936 941
28. N. Rougier, M.D. Kazatchkine, J.P. Rougier, V. Fremeaux-Bacchi, J. Blouin, and G. Deschenes Human complement factor H deficiency associated with hemolytic uremic syndrome J Am Soc Nephrol 9 1998 2318 2326
29. A. Bonnardeaux, and V. Pichette Complement dysregulation in haemolytic ureamic syndrome Lancet 362 2003 1514 1515
30. M.A. Dragon-Durey, and V. Fremeaux-Bacchi Atypical haemolytic uremic syndrome and mutations in complement regulator genes Springer Semin Immunopathol 27 2005 359 374
31. M. Noris, S. Brioschi, J. Caprioli, M. Todeschini, E. Bresin, and F. Porrati Familial haemolytic uraemic syndrome and an MCP mutation Lancet 362 2003 1542 1547
32. A. Richards, E.J. Kemp, M.K. Liszewski, J.A. Goodship, A.K. Lampe, and R. Decorte Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial haemolytic uremic syndrome Proc Natl Acad Sci U S A 100 2003 12966 12971
33. V. Fremeaux-Bacchi, E.A. Moulton, D. Kavanagh, M.A. Dragon-Durey, J. Blouin, and A. Caudy Genetic and functional analyses of membrane cofactor (CD46) mutations in atypical hemolytic uremic syndrome J Am Soc Nephrol 17 2006 2017 2025
34. J. Caprioli, P. Bettinaglio, P.F. Zipfel, B. Amadei, E. Daina, and S. Gamba The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat J Am Soc Nephrol 12 2001 297 307
35. V. Fremeaux-Bacchi, M.A. Dragon-Durey, J. Blouin, C. Vigneau, D. Kuypers, and B. Boudailliez Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome J Med Genet 41 2004 E84
36. M.A. Dragon-Durey, V. Frémeaux-Bacchi, C. Loirat, J. Blouin, P. Niaudet, and G. Deschenes Heterozygous and homozygous factor H deficiencies associated with haemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases J Am Soc Nephrol 15 2004 787 795
37. M.A. Dragon-Durey, C. Loirat, S. Cloarec, M.A. Macher, J. Blouin, and H. Nivet Anti-factor H autoantibodies associated with atypical haemolytic uremic syndrome J Am Soc Nephrol 16 2005 555 563
38. P.F. Zipfel Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage? Trends Immunol 22 2001 345 348
39. T. Manuelian, J. Hellwage, S. Meri, J. Caprioli, M. Noris, and S. Heinen Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in haemolytic uremic syndrome J Clin Invest 111 2003 1181 1190
40. E.R. Burns, and D. Zucker-Franklin Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells Blood 60 1982 1030 1037
41. H.M. Tsai, and E.C. Lian Antibodies to von Willebrand factor-cleaving protease in acute thrombocytopenic purpura N Engl J Med 339 1998 1585 1594
42. M. Galbusera, A. Benigni, S. Paris, P. Ruggenenti, C. Zoja, and C. Rossi Unrecognized pattern of von Willebrand factor abnormalities in hemolytic and uremic syndrome and thrombotic thrombocytopenic purpura J Am Soc Nephrol 10 1999 1234 1241
43. A.K. Chauhan, D.G. Motto, C.B. Lamb, W. Bergmeier, M. Dockal, and B. Plaimauer Systemic antithrombotic effects of ADAMTS13 J Exp Med 203 2006 767 776
44. A. Bonnefoy, K. Daenens, H.B. Feys, R. De Vos, P. Vandervoort, and J. Vermylen Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13 Blood 107 2006 955 964
45. S. Savasan, S.K. Lee, D. Ginsburg, and H.M. Tsai ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity Blood 101 2003 4449 4451
46. C.L. Bennett, P.D. Weinberg, K. Rozenberg-Ben-Dror, P.R. Yarnold, H.C. Kwaan, and D. Green Thrombotic thrombocytopenic purpura associated with ticlopidine: a review of 60 cases Ann Intern Med 128 1998 541 544
47. Y. Page, B. Tardy, F. Zeni, C. Comtet, R. Terrana, and J.C. Bertrand Thrombotic thrombocytopenic purpura related to ticlopidine Lancet 337 1991 774 776
48. C.L. Bennett, J.M. Connors, J.M. Carwile, J.L. Moake, W.R. Bell, and S.R. Tarantolo Thrombotic thrombocytopenic purpura associated with clopidogrel N Engl J Med 342 2000 1773 1777
49. F. Fakhouri, J.P. Vernant, A. Veyradier, M. Wolf, G. Kaplanski, and R. Binaut Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases Blood 106 2005 1932 1937
50. R.M. Petitt Thrombotic thrombocytopenic purpura: a thirty-year review Semin Thromb Hemost 6 1980 350 355
51. A.P. Bos, R.A. Donckerwolcke, and A.J. Van Vught The hemolytic-uremic syndrome: prognostic significance of neurological abnormalities Helv Paediatr Acta 40 1985 381 389
52. G. Eknoyan, and S.A. Riggs Renal involvement in patients with thrombotic thrombocytopenic purpura Am J Nephrol 6 1986 117 131
53. R.L. Ridolfi, and W.R. Bell Thrombotic thrombocytopenic purpura: report of 25 cases and a review of the literature Medicine 60 1981 413 428
54. R.C. Bone, J.E. Henry, and J. Petterson Respiratory dysfunction in thrombotic thrombocytopenic purpura Am J Med 65 1978 262 270
55. S.P. Andreoli, and J.M. Bergstein Development of insulin-dependent diabetes mellitus during the hemolytic-uremic syndrome J Pediatr 100 1982 541 545
56. S.P. Andreoli, and J.M. Bergstein Acute rhabdomyolysis associated with haemolytic-uremic syndrome J Pediatr 103 1983 78 80
57. I. Tostivint, B. Mougenot, A. Flahault, C. Vigneau, M.A. Costa, and J.P. Haymann Adult haemolytic and uraemic syndrome: causes and prognostic factors in the last decade Nephrol Dial Transplant 17 2002 1228 1234
58. R.M. Bukowski Thrombotic thrombocytopenic purpura: a review Prog Hemost Thromb 6 1982 287 337
59. J.J. Byrnes, and J.L. Moake Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy Clin Hematol 15 1986 413 442
60. J.S. Fong, and B.S. Kaplan Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet "exhaustion" Blood 60 1982 564 570
61. B.S. Kaplan, P.C. Thomson, and G.M. McNab Serum complement levels in haemolytic-uraemic syndrome Lancet 2 1973 1505 1506
62. M. Hollenbeck, B. Kutkuhn, C. Aul, M. Leschke, R. Willers, and B. Grabensee Haemolytic-uremic syndrome and thrombotic-thrombocytopenic purpura in adults: clinical findings and prognostic factors for death and end stage renal disease Nephrol Dial Transplant 13 1998 76 81
63. French cooperative study group for adult HUS Adult hemolytic uremic syndrome with renal microangiopathy. Outcome according to therapeutic protocol in 53 cases Ann Med Interne (Paris) 143 (suppl) 1 1992 27 32
64. L. Morel-Maroger, A. Kanfer, K. Solez, J.D. Sraer, and G. Richet Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic-uremic syndrome) clinicopathologic study in 20 adults Kidney Int 15 1979 548 555
65. P. Mal, A. Meyrier, P. Callard, D. Kleinknecht, J.J. Altmann, and M. Beaugrand The diagnostic yield of transjugular renal biopsy. Experience in 200 cases Kidney Int 41 1992 445 449
66. É. Rondeau, B. Mougenot, R. Lacave, M.N. Peraldi, E.K. Kruithof, and J.D. Sraer Plasminogen activator inhibitor in renal fibrin deposits of human nephropathies Clin Nephrol 33 1990 55 60
67. Y. Asada, A. Sumiyoshi, T. Hayashi, J. Suzumiya, and K. Kaketani Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen Thromb Res 38 1985 469 479
68. A. Gonzalo, F. Mampaso, and N. Gallego Hemolytic uremic syndrome with hypocomplementemia and deposits of IgM and C3 in the involved renal tissue Clin Nephrol 16 1981 193 199
69. M.J. Mant, M.N. Cauchi, and G. Medley Thrombotic thrombocytopenic purpura: report of a case with possible immune etiology Blood 40 1972 416 421
70. C.S. Wong, S. Jelacic, R.L. Habeeb, S.L. Watkins, and P.I. Tarr The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157: H7 infections N Engl J Med 342 2000 1930 1936
71. J.N. Georges How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Blood 96 2000 1223 1229
72. G.A. Rock, K.H. Shumak, N.A. Buskard, V.S. Blanchette, J.G. Kelton, and R.C. Nair Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura N Engl J Med 325 1991 393 397
73. C. Loirat, E. Sonsino, N. Hinglais, J.P. Jais, P. Landais, and J. Fermanian Treatment of the childhood haemolytic uraemic syndrome with plasma: a multicentre randomized controlled trial Pediatr Nephrol 2 1988 279 285
74. K.R. Baker, and J.L. Moake Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome Curr Opin Pediatr 12 2000 23 28
75. S. Dundas, J. Murphy, R.L. Soutar, G.A. Jones, S.J. Hutchinson, and W.T. Todd Effectiveness of therapeutic exchange in the 1996 Lanarkshire Escherichia coli O157: H7 outbreak Lancet 354 1999 1327 1330
76. J. Caprioli, M. Noris, S. Brioschi, G. Pianetti, F. Castelletti, and P. Bettinaglio Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome Blood 108 2006 1267 1279
77. W.R. Bell, H.G. Braine, P.M. Ness, and T.S. Kickler Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients N Engl J Med 325 1991 398 403
78. J. Nürnberger, O. Witzke, A. Opazo Saez, U. Vester, H.A. Baba, and A. Kribben Eculizumab for atypical hemolytic-uremic syndrome N Engl J Med. 360 5 2009 Jan 29 542 544
79. R.A. Gruppo, and R.P. Rother Eculizumab for congenital atypical hemolytic-uremic syndrome N Engl J Med. 360 5 2009 Jan 29 544 546
80. J.R. Stapp, S. Jelacic, Y.L. Yea, E.J. Klein, M. Fischer, and C.R. Clausen Comparison of Escherichia coli O157:H7 antigen detection in stool and broth cultures to that in sorbitol-MacConkey agar stool cultures J Clin Microbiol 38 2000 3404 3406
81. C. Badid, B. McGregor, J.M. Faivre, A. Guerard, L. Juillard, and D. Fouque Renal thrombotic microangiopathie induced by interferon Nephrol Dial Transplant 16 2001 846 848
82. N.F. Crum, and P. Gable Quinine-induced hemolytic-uremic syndrome South Med J 93 2000 726 728
83. M.C. Fung, A.M. Storniolo, B. Nguyen, M. Arning, W. Brookfield, and J. Vigil A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy Cancer 85 1999 2023 2032
84. M.N. Peraldi, C. Maslo, K. Akposso, B. Mougenot, É Rondeau, and J.D. Sraer Acute renal failure in the course of HIV infection: a single-institution retrospective study of ninety-two patients and sixty renal biopsies Nephrol Dial Transplant 14 1999 1578 1585
85. J. Barbot, E. Costa, M. Guerra, M.S. Barreirinho, P. Isvarlal, and R. Robles Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of vonWillebrand factor-cleaving protease Br J Haematol 113 2001 649 651
86. M. Noris, S. Bucchioni, M. Galbusera, R. Donadelli, E. Bresin, and F. Castelletti Complement factor H mutation in familial thrombotic thrombocytopenic purpura with DAMTS13 deficiency and renal involvement J Am Soc Nephrol 16 2005 1177 1183
87. C.P. Weiner Thrombotic microangiopathy in pregnancy and the postpartum period Semin Hematol 24 1987 119 129
88. M.D. Sibai Imitators of severe preeclampsia Obstet Gynecol 109 2007 956 966
89. A. Kanfer Insuffisances rénales aiguës gravidiques et du post-partum Rev Prat 27 1977 503 509
90. F. Fakhouri, M. Jablonski, J. Lepercq, J. Blouin, A. Benachi, and M. Hourmant Blood. 112 12 2008 Dec 1 4542 4545
91. L.I. Gordon, and H.C. Kwaan Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura: hemolytic uremic syndrome in the cancer patient Semin Thromb Hemost 25 1999 217 221
92. O. Ortega Marcos, F. Escuin, J.L. Miguel, P. Gomez-Fernandez, M. Perez Fontan, and R. Selgas Hemolytic uremic syndrome in a patient with gastric adenocarcinoma: partial recovery of renal function after gastrectomy Clin Nephrol 24 1985 265 268
93. D. Donald, and A.A. Dawson Microangiopathic haemolytic anaemia associated with malignant haemangio-endothelioma J Clin Pathol 24 1971 456 459
94. K.K. Francis, N. Kalyanam, D.R. Terrell, S.K. Vesely, and J.N. George Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases Oncologist 12 2007 11 19
95. A.J. Murgo Thrombotic microangiopathy in cancer patient including those induced by chemotherapeutic agents Semin Hematol 24 1987 161 177
96. K. Kojouri, and J.N. George Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation Curr Opin Oncol 19 2007 148 154
97. T. Ruutu, G. Barosi, R.J. Benjamin, R.E. Clark, J.N. George, and A. Gratwohl Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group Haematologica 92 2007 95 100
98. F. Peyvandi, S.M. Siboni, D. Lambertenghi Deliliers, S. Lavoretano, N. De Fazio, and B. Moroni Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation Br J Haematol 134 2006 187 195
99. T. Hahn, A.R. Alam, D. Lawrence, L. Ford, M.R. Baer, and B. Bambach Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion Transplantation 78 2004 1515 1522
100. M. Gisselbrecht, P. Cohen, O. Lortholary, B. Jarrousse, M. Gayraud, and I. Lecompte Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome Am J Kidney Dis 33 1999 133 137
101. H.M. Trimarchi, L.D. Truong, S. Brennan, J.M. Gonzalez, and W.N. Suki FK-506-associated thrombotic microangiopathy Transplantation 67 1999 539 544
102. C. Frangié, C. Lefaucheur, J. Medioni, C. Jacquot, G.S. Hill, and D. Nochy Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma Lancet Oncol 8 2007 177 178
103. D. Roncone, A. Satoskar, T. Nadasdy, J.P. Monk, and B.H. Rovin Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma Nat Clin Pract Nephrol 3 2007 287 293
104. P.J. Cannon, M. Hassar, D.B. Case, W.J. Casarella, S.C. Sommers, and E.C. Le Roy The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation Medicine 53 1974 1 46
105. P.J. Cannon Le rein de la sclérodermie. J. Hamburger, J. Crosnier, J.P. Grunfeld, Néphrologie 1979 Flammarion Médecine-Sciences; Paris 650 658
106. T.A. Medsger Jr., and A.T. Masi Survival with scleroderma. Il. A life table analysis of clinical and demographic factors in 358 male US veteran patients J Chronic Dis 26 1973 647 660
107. G. Richet, B. Mougenot, and J. Roland Atteintes rénales des sclérodermies Ann Med Interne (Paris) 135 1984 594 600
108. V.D. Steen, T.A. Medsger Jr., T.A. Osial Jr., G.L. Ziegler, A.P. Shapiro, and G.P. Rodnan Factors predicting development of renal involvement in progressive systemic sclerosis Am J Med 76 1984 779 786
109. M. Lam, E. Ricanati, M.A. Khan, and I. Kushner Reversal of severe renal failure in systemic sclerosis Ann Intern Med 89 1978 642 643
110. J.A. Lopez Ovejero, S.D. Saal, W.A. D'Angelo, J.S. Cheigh, K.H. Stenzel, and J.H. Laragh Reversal of vascular and renal crisis of scleroderma by oral angiotensin converting enzyme blockade N Engl J Med 300 1979 1417 1419
111. G.E. Merino, D.E. Sutherland, C.M. Kjellstrand, R.L. Simmons, and J.S. Najarian Renal transplantation for progressive systemic sclerosis with renal failure. Case report and review of previous experience Am J Surg 133 1977 745 749
112. N.M. Simon, M.B. Graham, and F.A. Kyser Resolution of renal failure with malignant hypertension in scleroderma. Case report and review of the literature Am J Med 67 1979 533 539
113. C. Vigneau, and É. Rondeau Hemolytic and uremic syndrome in the adult Nephrologie 23 2002 165 171
114. D. Nochy, D. Barres, J.P. Camilleri, J. Bariety, P. Corvol, and J. Menard Abnormalities of renin-containing cells in human glomerular and vascular renal diseases Kidney Int 23 1983 375 379
115. I. Uthman, and M. Khamasha Antiphospholipid syndrome and the kidneys Semin Arthritis Rheum 35 2006 360 367
116. J.C. Reynolds, L.Y. Agodoa, C.M. Yuan, and K.C. Abbott Thrombotic microangiopathy after renal transplantation in the United States Am J Kidney Dis 42 2003 1058 1068
117. A. Lahlou, P. Lang, B. Charpentier, B. Barrou, D. Glotz, and C. Baron Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Coopératif de l'Ile-de-France Medicine 79 2000 90 102
118. C. Loirat, and P. Niaudet The risk of recurrence of haemolytic uremic syndrome after renal transplantation in children Pediatr Nephrol 18 2003 1095 1101